Skip to main content
IMCR logo

IMCR · Immunocore Holdings plc · Analyst Estimates

Track IMCR — free
$26.41 -0.22 (-0.83%) At close · Nov 20 Q4 2025 earnings call transcript
Market Cap
$1.36B
Shares
51.68M
Volume · Nov 20 546.2K Avg daily vol (3M) 449.07K

Analyst Estimates

Compare analyst forecasts for Immunocore Holdings plc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-21 11:15 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.32
-0.20
-0.03
9
-0.19
-0.041
-0.051
-0.022
1
5
1
1
Revenue
USD
Publication date not stated
429.60M
437.15M
444.20M
11
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-1.33
-0.64
0.05
11
-0.90
-0.75
-0.75
-0.74
1
3
1
2
Revenue
USD
Publication date not stated
448.66M
480.46M
559.80M
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.44
-0.19
0.01
11
-0.14
-0.18
-0.19
-0.17
0
1
1
1
Revenue
USD
Publication date not stated
104.78M
112.26M
119.40M
11
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD · Non-GAAP
Publication date not stated
-0.22
-0.11
-0.03
5
-0.11
-0.094
-0.14
-0.14
0
0
0
0
Revenue
USD
Publication date not stated
110.57M
119.86M
132.50M
5
— — — — — — — —
Key facts CIK 1671927 CUSIP 45258D105 13F (30d) 150 filings 122 filers Visit website Investor relations